Routes of Administration: Injection and Oral Capsules BPC-157 can be administered in two primary forms, each with its own advantages depending on the intended use: Subcutaneous Injection: Direct and Targeted: Injections allow for direct delivery into the bloodstream, making it the preferred route for systemic effects or for targeting specific injuries
Bowel Adhesion and Therapy With the Stable Gastric Pentadecapeptide BPC 157, L-NAME and L-Arginine in Rats
Since BPC-157 has not undergone clinical testing in humans, there is no established dosing, no safety profile and no information on potential long-term risks
Many methodological validations were not included because of the limited space of the article
Measurement: 1.0 mg equals 3 units, 1.5 mg equals 4.5 units, and 2.0 mg equals 6 units
No representations or warranties are made regarding safety, effectiveness, or outcomes